.png)
Lighthouse
Diversity in Cancer Clinical Trials: Issues and Solutions
Cancer clinical trial diversity is poor, which matters because of different treatment responses. Solutions are vital to improve trials.
top of page
Lighthouse
Clinical Trial Delays in Europe after New Diagnostic Device Regulation
Half of all EU clinical trials are currently running behind schedule due to problems with new regulations for diagnostic medical devices.
Lighthouse
Three CMO Need-to-Knows about Clinical Trial Awareness
A CMO is responsible for compound development success, so building awareness proactively and compliantly is critical for clinical trials.
bottom of page